5 results  1 of 1 

1 Clinical Characteristics and Outcomes of Patients with Culture-Negative Pyogenic Spondylitis according to Empiric Glycopeptide Use
Yong Dae Lee, Yoon Hee Jeon, Young-Hoon Kim, Kee-Yong Ha, Jung-Woo Hur, Kyeong-Sik Ryu, Jin-Sung Kim, Youn Jeong Kim
Infect Chemother.2019;51(3):274-283.   Published online 2019 September 6     DOI: http://dx.doi.org/10.3947/ic.2019.51.3.274
      
2 Prevalence and Clinical Impact of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolated From Hospitalized Patients
Young Rae Koh, Kye-Hyung Kim, Chulhun L. Chang, Jongyoun Yi
Ann Lab Med.2016;36(3):235-243.   Published online 2016 February 23     DOI: http://dx.doi.org/10.3343/alm.2016.36.3.235
      
3 Glycopeptide Antibiotics: Structure and Mechanisms of Action
Hee-Kyoung Kang, Yoonkyung Park
J Bacteriol Virol.2015;45(2):67-78.   Published online 2015 February 9     DOI: http://dx.doi.org/10.4167/jbv.2015.45.2.67
   
4 Susceptibility of Glycopeptide-Resistant Enterococci to Linezolid, Quinupristin/dalfopristin, Tigecycline and Daptomycin in a Tertiary Greek Hospital
Sofia Maraki, George Samonis, Dimitra Dimopoulou, Elpis Mantadakis
Infect Chemother.2014;46(4):253-256.   Published online 2014 December 29     DOI: http://dx.doi.org/10.3947/ic.2014.46.4.253
      
5 Antimicrobial resistance in enterococci
Chik Hyun Pai, Mi-Na Kim
Yonsei Med J.1998;39(6):554-561.   Published online 2002 February 20     DOI: http://dx.doi.org/10.3349/ymj.1998.39.6.554
      

 1 of 1